Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 81 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8450339

    Compositions for treatment of common cold

    Takeda Pharma A/S · Granted May 28, 2013 · Expires May 23, 2033

    granted

  2. US 8450299

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  3. US 8445507

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  4. US 8440208

    Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted

  5. US 8431561

    Methods and compositions for treatment of excess nitric oxide or cyanide toxicity

    The Regents of the University of California · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  6. US 8431532

    FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same

    Five Prime Therapeutics, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  7. US 8426597

    Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases

    CARDIOLYNX AG · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  8. US 8420099

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  9. US 8420612

    Diabetes treatment methods and drug targets therefor

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  10. US 8415332

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  11. US 8414890

    Human antibodies to human RANKL, encoding nucleic acids and methods of treatment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  12. US 8410081

    Treatment of cystic fibrosis

    ACADEMISCH MEDISCH CENTRUM · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  13. US 8409548

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  14. US 8410292

    Epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  15. US 8410073

    Methods and compositions for prevention or treatment of RSV infection

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  16. US 8404869

    Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

    MAZENCE INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  17. US 8404711

    5-HT4 receptor agonist compounds for treatment of cognitive disorders

    Theravance, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  18. US 8399018

    Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  19. US 8399421

    Treatment for neuropathic pain due to spinal cord injury

    The Board of Regents of the University of Texas System · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  20. US 8383388

    Modified coagulation factor IX polypeptides and use thereof for treatment

    Catalyst Biosciences, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  21. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  22. US 8377450

    Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer

    United Cancer Research Institute · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  23. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  24. US 8361710

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.